Genesis Therapeutics
Drausin Wulsin is a seasoned machine learning professional with extensive experience in developing and implementing advanced technologies across various sectors. Currently serving as Senior Principal Machine Learning Engineer at Genesis Therapeutics since April 2025, Drausin also acts as a ML Advisor for startups, focusing on delivering business value through machine learning initiatives. Previously, as a Machine Learning Scientist at Arena from January 2024 to April 2025, Drausin led the development of enterprise-grade multimodal foundational models and reinforcement learning agents. As the first hire at Immunai, Drausin directed the machine learning team to innovate therapies by leveraging insights into the immune system. Other notable roles include leadership positions at Cedar and Oscar Insurance, with early career experience at Palantir Technologies. Drausin holds a Ph.D. in Bioengineering from the University of Pennsylvania and a Bachelor's degree in Biomedical Engineering from Yale University.
This person is not in any teams
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.